Delivery Order SPE2DB20D1100-SPE2DB23FD8T9
Award Date 9/26/23
Potential Completion Date 9/27/23
Potential Value $5.3K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $733.80 firm fixed price delivery order contract to Amerisourcebergen Drug Corporation for 4561436388 mitomycin 5 mg vials. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical products to the agency's location in Conshohocken, Pennsylvania by July 10, 2023 under the terms of this short-term order. No subcontractors or set aside designations were indicated. The Defense Logistics Agency functions to provide...
- The Defense Logistics Agency awarded a $6,758 delivery order to Amerisourcebergen Drug Corporation for 4562195244 mitomycin 20 mg vials. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania by September 18, 2023 under the firm fixed price contract awarded on September 15, 2023. The Defense Logistics Agency utilizes indefinite delivery/indefinite quantity contracts to support medical readiness for the Department of...
- The Defense Logistics Agency awarded a $337 firm fixed price delivery order contract to Amerisourcebergen Drug Corporation to provide 4562066016 Mitomycin 5 mg vials. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania by September 7, 2023 under the terms of the order. No subcontractors or set aside designations were specified. The Defense Logistics Agency supports Department of Defense procurement programs through...
- The Defense Logistics Agency awarded a delivery order valued at $1,146.40 to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Mitomycin 5 mg vials. This is a firm fixed-price delivery order with an ultimate completion date of November 7, 2025, and represents a non-set-aside competitive award. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $2,754.00 delivery order to AmerisourceBergen Drug Corp for the supply of Mitomycin 20 mg vials under a firm fixed-price contract with an ultimate completion date of October 27, 2025. This competitively awarded, non-set-aside delivery order leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The...
- The Defense Logistics Agency awarded a $2,448 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Mitomycin 40 mg vials, with completion targeted for September 16, 2025. This firm fixed-price contract is a non-set-aside award executed as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999 through December 2026. The pharmaceutical will be...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,250,777 units of Mitomycin 5 mg vials, a chemotherapy medication. The contract has a firm fixed price of $2,751.36 and a completion date of May 15, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $1,847 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 500 mg/20 ml vials of Mitigo. As the prime contractor, Amerisourcebergen will deliver 20 ml vials of the specified pharmaceutical to the location in Conshohocken, Pennsylvania within the period of performance between July 18-19, 2023. The delivery order was placed against an existing DLA contract vehicle in support of the Agency's medical supply procurement programs. No set...
- Amerisourcebergen Drug Corp has received a $3,223.10 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply 20 mg vials of mitomycin. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania with completion by December 1, 2023. As a prime contractor and subsidiary of Amerisourcebergen Corporation, Amerisourcebergen Drug Corp routinely obtains contracts through DLA Troop Support Medical to provide...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $30,000 to Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation. The order is for one gram vials of the chemotherapy drug methotrexate to be delivered to a facility in Conshohocken, Pennsylvania over a one-day period in August 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense globally, this award supports the Defense Logistics...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB23FD8T9Delivery Order
The Defense Logistics Agency awarded a $5,326 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562312732 units of 5 mg Mitomycin vials. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to its Conshohocken, Pennsylvania facility by September 27, 2023 to support the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were identified. The delivery order was issued against an existing DLA contract vehicle to fulfill requirements for oncology drug therapies.
Generated 12/26/23, 9:22 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 9/26/23 |